{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Albemarle Corp.
Albemarle Corp. Hits Day High with Strong 7.21% Intraday Surge
Albemarle Corp., a small-cap specialty chemicals company, saw a significant intraday gain, contrasting with a decline in the S&P 500. Despite recent positive trends, the company has faced challenges over the past year, reporting consecutive quarterly losses and declining net sales and profits. Its market cap is USD 9,650 million.
Albemarle Corp. Hits Day Low of $79.30 Amid Price Pressure
Albemarle Corp., a small-cap specialty chemicals company, saw its stock decline significantly amid ongoing challenges. Over the past year, net sales dropped by 29.31%, and net profit fell by 83.03%. The company has reported negative results for seven consecutive quarters, underperforming against the S&P 500.
Albemarle Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators
Albemarle Corp., a small-cap specialty chemicals company, has recently revised its evaluation amid market fluctuations. The stock, currently priced at $81.84, has shown significant volatility over the past year, with a 52-week range from $49.43 to $113.91, reflecting ongoing recovery efforts against broader market trends.
Is Albemarle Corp. technically bullish or bearish?
As of September 10, 2025, Albemarle Corp. shows a mildly bullish technical trend, supported by positive MACD and moving averages, but has significantly underperformed the S&P 500 with a year-to-date return of -5.98% compared to 12.22%.
Is Albemarle Corp. overvalued or undervalued?
As of July 31, 2024, Albemarle Corp. is considered risky and overvalued with a P/E ratio of 7040 and an EV to EBITDA of 56.37, significantly higher than its peers, and has underperformed the S&P 500 with a year-to-date return of -5.98%.
Is Albemarle Corp. technically bullish or bearish?
As of June 6, 2025, Albemarle Corp. shows a mildly bearish trend, with conflicting signals across time frames, including a mildly bullish weekly MACD and bearish monthly indicators.
Is Albemarle Corp. overvalued or undervalued?
As of July 31, 2024, Albemarle Corp. is considered overvalued with a risky valuation grade, reflected in its high P/E ratio of 7040 and poor performance, including a year-to-date return of -32.83% compared to the S&P 500's 2.44% gain.
Who are in the management team of Albemarle Corp.?
As of March 2022, the management team of Albemarle Corp. includes Jerry Masters as Chairman, President, and CEO, with James O'Brien as Lead Independent Director and independent directors Mary Brlas, Glenda Minor, Diarmuid O'Connell, and Dean Seavers.
What does Albemarle Corp. do?
Albemarle Corporation is a global developer and manufacturer of specialty chemicals, classified as a mid-cap company with a market cap of approximately $7 billion. As of March 2025, it reported net sales of $1.077 billion and a net profit of $49 million.
How big is Albemarle Corp.?
As of Jun 18, Albemarle Corp. has a market capitalization of 7,023.18 million, with net sales of 5,093.66 million and a net profit loss of 1,102.82 million over the latest four quarters. Shareholder's funds are at 9,961.52 million, and total assets amount to 16,609.65 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
